Therapeutic Potential of Psilocybin in Alcohol and Opioid Use Disorders: A Promising Role for Psychedelics
Elmira Zolali, Lance R Mcmahon, Samuel Obeng
Pharmaceutical Sciences April 30, 2026 DOI: 10.34172/ps.026.43663 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Psilocybin Addiction |
| Keywords | Hallucinogen Alcohol Opioid Drug Depression economics Pharmacology |
Abstract
Please don't use dangerous characters * Last Name Please don't use dangerous characters * Email Address Please enter a email address * Comments Please don't use dangerous characters * Security code The entered code is invalid. Generate New Image Type the code from the image Abstract View: 388 Your browser does not support the canvas element. yearsJanFebMarAprMayJunJulAugSepOctNovDec 20262647514132203153 PDF Download: 376 Your browser does not support the canvas element.
Citations in the library
Cites 20
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder JAMA Psychiatry August 24, 2022
- Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Frontiers in Psychiatry January 22, 2020
- Psilocybin, psychological distress, and suicidality Journal of Psychopharmacology September 1, 2015
and 15 more in the library